Products

UltraBiotic 45

Multistrain Probiotic 45 Billion CFU per Capsule

UltraBiotic 45 contains probiotics that support digestive system health and function.

UltraBiotic 45 contains probiotics that support digestive system health and function, relieve abdominal bloating and help maintain beneficial intestinal flora including during antibiotic use. S. thermophilus (CUL 68) aids in the digestion of lactose. UltraBiotic 45 contains L. acidophilus (CUL 21 + CUL 60), B animalis ssp. lactis (CUL 34) and B. bifidum (CUL 20) that are shown to relieve symptoms of medically diagnosed irritable bowel syndrome.

Product Requires Refrigeration : Yes
Serving Type: Capsule
Available in Sizes: 30 capsules 60 capsules Dosage: Adults: Take 1-2 capsules once a day, or as professionally prescribed.

Where to buy

Product Features

Lab4 probiotics (CUL 60, CUL 21, CUL 34, CUL 20) contribute to the relief of symptoms of medically diagnosed irritable bowel syndrome including, reducing abdominal pain and bloating, reducing the occurrence of constipation and diarrhoea and supporting general health and wellbeing.
Lab4 probiotics support beneficial gut flora during antibiotic use and help to restore beneficial gut flora after antibiotic use.
Probiotics support intestinal beneficial flora.
Probiotics support immune system health and function.
Probiotics support healthy digestive system function and health.
Probiotics relieve abdominal bloating.
Streptococcus thermopilus aids digestion of lactose.

Ingredients

Lactobacillus rhamnosus CUL 63	15.6 billion CFU*
Lactobacillus casei CUL 06	9.5 billion CFU
Lactobacillus acidophilus CUL 21 + CUL 60	7.4 billion CFU
Bifidobacterium animalis ssp. lactis CUL 34	4.3 billion CFU
Lactobacillus plantarum CUL 66	3.2 billion CFU
Streptococcus thermophilus CUL 68	2.3 billion CFU
Lactobacillus fermentum CUL 67	1.4 billion CFU
Bifidobacterium breve Bb-18	1.4 billion CFU
Bifidobacterium bifidum CUL 20	225 million CFU

Warning

KEEP OUT OF REACH OF CHILDREN
Always read the label and follow the directions for use.
If you are pregnant or breastfeeding, talk to your health professional before use.
Drink plenty of water.
Do not use when abdominal pain, nausea or vomiting are present or if you develop diarrhoea.
Seek medical attention if diarrhoea persists for more than 48 hours in adults.
If symptoms persist, worsen or change unexpectedly, talk to your health professional.
If you have any pre-existing conditions, are on any medications, always talk to your health professional before use.
Some products should be ceased at least two weeks before any elective surgery, please confirm with your health professional.
Contains sugars.

Evidence

[1] Allen SJ, Okoko B, Martinez E, et al. Probiotics for treating infectious diarrhoea. The Cochrane Database of Systematic Reviews, 2003;4.
[2] Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. The American Journal of Clinical Nutrition, 2001;73(2):399s-405s.
[3] Didari T, Mozaffari S, Nikfar S, et al. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol, 215;21(1):3072-3084.
[4] Hawrelak JA. Probiotics. In: Pizzorno JE Jr, Murray MT (Eds), Textbook of natural medicine, 3rd ed, 2006; pp.1195-1215.
[5] Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol, 2004;38(6):S104-S106.
[6] Tien MT, Girardin SE, Regnault B, et al. Anti-inflammatory effect of Lactobacillus casei on Shigella-infected human intestinal epithelial cells. J Immunol, 2006;176(2):1228-1237.
[7] Fooks LJ, Gibson GR. Br J Nutr 2002;88 Suppl 1:S39-S49.
[8] Hessle C, Hanson LA, Wold AE. Clin Exp Immunol 1999;116(2):276-282.
[9] Martini MC, Lerebours EC, Lin WJ, et al. Am J Clin Nutr 1991;54(6):1041-1046.
[10] Yasui H, Shida K, Matsuzaki T, et al. Antonie Van Leeuwenhoek 1999;76(1-4):383-389.
[11] Thibault H, Aubert-Jacquin C, Goulet O. J Pediatr Gastroenterol Nutr 2004;39(2):147-152.
[12] Guyonnet D. Fermented milk containing Bifidobacterium lactis DN-173 010 improved self-reported digestive comfort amongst a general population of adults. A randomized, open-label, controlled, pilot study. J Dig Dis, 2009;10(1):61-70.